Prions (37) are protein isoforms that are capable of reproducing themselves by converting normal proteins of the same primary structure into a prion state. In mammals, including humans, the prion protein PrP Sc is associated with infectious neurodegenerative diseases, such as mad cow disease (see reference 38 for a review). In yeast and fungi, prions serve as protein-based genetic elements, inherited via cytoplasm in a non-Mendelian fashion (see references 5, 46, and 52 for reviews). Prions form insoluble proteinase-resistant aggregates in vivo, in contrast to their normal (nonprion) counterparts, which are usually soluble. In vitro, prion proteins form amyloid-like polymers. It has been suggested that in vivo replication of prion conformation occurs by a nucleated polymerization mechanism (25, 26) . This relates prion phenomena to other amyloidoses and neural inclusion disorders (see reference 21 for a review). An alternative model explains replication of prion conformation via a monomer-directed or template-assisted conformational switch in the heterodimer, suggesting that aggregate formation occurs as a consequence of the conformational switch (see reference 17 for a review). Recent data indicate that in vitro propagation of the yeast prion amyloids may combine features of both models and therefore could be termed a nucleated conformational conversion (45) .
Since prion propagation apparently operates at the level of protein folding and assembly, it is likely that chaperone proteins, which assist in the protein folding and assembly and disassembly events, are involved in this process. Indeed, propagation of the yeast prion [PSI ϩ ], an aggregation-prone isoform of the translational termination factor Sup35 (eRF3), is modulated by the chaperones of Hsp100 (8) and Hsp70 (7, 18, 31) [URE3] is an aggregation-prone isoform of the Ure2 protein involved in regulation of nitrogen metabolism (53) , while [PIN ϩ ] is a non-Mendelian element of an unidentified molecular nature that influences the efficiency of the de novo appearance of [PSI ϩ ] (9, 10). Thus, Hsp104 is likely to play a universal role in the replication of yeast prions of various origins.
Yeast Hsp104 protein is a homohexameric ATPase (33) of the evolutionarily conserved ClpB/Hsp100 family (43) , which functions in solubilization and refolding of aggregated proteins damaged by heat stress (15, 32) as well as in protection of yeast cells from some other protein-damaging stresses (40) . This provides an explanation for [PSI ϩ ] curing by excess Hsp104. Indeed, it has been confirmed that Hsp104 overproduction in [PSI ϩ ] (that is, prion-containing) strains results in the shift of Sup35 from the insoluble (aggregated) to the soluble fraction (34, 35) . It is more difficult to explain why moderate levels of Hsp104 are required for [PSI ϩ ] propagation. The following models for this phenomenon have been discussed (see reference 52 for a review).
Model I states that Hsp104 is required for converting the cellular Sup35 protein into a partially unfolded intermediate, which serves as a substrate for prion conversion (8) . Although this model in its original form did not necessitate Hsp104 involvement in the actual process of prion conversion, further modification of the model was proposed (34, 46) , suggesting that Hsp104 might also facilitate prion conversion by combin-ing the partially unfolded Sup35 molecules into oligomeric complexes. Indeed, Sup35 amyloid formation in vitro appears to proceed via oligomers of partially unfolded Sup35 molecules (45) . In either version of the model, the absence of Hsp104 would block formation of the new prion molecules without affecting the preexisting prion aggregates. Therefore, this model predicts that prion loss induced by inactivation of Hsp104 should occur in a slow generation-dependent manner by dilution of unaltered preexisting aggregates in cell divisions.
Model II asserts that Hsp104 is responsible for production of prion seeds, that is, breaking the prion aggregates down into the smaller oligomers. Although this model in its original form stated that the absence of Hsp104 affects prion partitioning and segregation to the daughter cells (25, 35) , it is also clear that seeds are required to initiate the new rounds of prion replication. Thus, this model predicts that the size of preexisting prion aggregates should increase due to continuous prion conversion in the absence of the Hsp104-mediated seeding. In addition to the loss of preexisting aggregates by dilution, their transmissibility could be impaired by increased size, resulting in rapid loss of active prion units.
In agreement with model II, in vitro formation of the Sup35 amyloid does not require Hsp104 (14, 45) . However, it has been shown that the Sup35 protein, isolated from the heterologous system for in vitro experiments, is already partially unfolded, which could also explain a lack of Hsp104 requirement for in vitro amyloid formation (45) . Thus, in vivo experiments are required to choose between the models.
A chemical agent, guanidine-HCl (GuHCl), has been identified (49) which causes [PSI ϩ ] loss in a strict generationdependent manner, apparently by a dilution mechanism due to a blocking of [PSI ϩ ] proliferation (12) . GuHCl also cures [URE3] (53) and [PIN ϩ ] (9). While GuHCl increases Hsp104 expression (8, 27) , this increase is not sufficient to explain the prion-curing effect of GuHCl (9, 12) . GuHCl is a proteindenaturing agent. However, the concentrations used in prioncuring experiments (1 to 5 mM) were not high enough to cause protein denaturing. On the other hand, these concentrations of GuHCl inhibited the ATPase activity of Hsp104 in vitro (15) . This led to the suggestion that GuHCl cures yeast cells of prions by inactivating Hsp104 (12, 15) .
Here we performed a detailed study of prion loss after Hsp104 inactivation. Kinetic parameters of prion loss and physical characteristics of the Sup35
PSIϩ aggregates confirm that Hsp104 inactivation causes rapid increase of aggregate size and loss of prion replicating ability, which are difficult to explain by a simple dilution mechanism. Thus, consequences of Hsp104 inactivation are different from those observed in the case of GuHCl treatment and are consistent with the model postulating the role of Hsp104 in the production of new prion seeds.
MATERIALS AND METHODS
Yeast strains. (8) . The strains GT81, which is a self diploid of GT56-35D, and GT82, which is a self diploid of GT56-11D, were described previously (6) . GT81-1C (MATa) (7) and GT81-1D (MAT␣) (7) are haploid meiotic spore clones of GT81. GT234 is a [psi Ϫ pin Ϫ ] meiotic segregant of GT81, cured of [PSI ϩ ] and [PIN ϩ ] by GuHCl. GT84 (7) and GT87 (this study) are derivatives of GT81 and GT82, respectively, in which a piece of DNA corresponding to the portion of the HSP104 promoter and open reading frame (ORF) (except for the C-terminal region) was removed from one homolog and replaced by the URA3 gene as described previously (8) . The hsp104⌬::URA3 disruption allele was verified by Southern hybridization. GT241-2B and GT241-3B are hsp104⌬ meiotic spore clones of GT84. GT238-1A and GT238-6C are hsp104⌬ meiotic spore clones of GT84 bearing the plasmid pGHPM104 (see below). R. Wickner kindly provided strain YHE64 (called OT113 in our collection), which contains the yeast prion [URE3-2] (13). The hsp104⌬ derivative of YHE64 was constructed by replacing the portion of the HSP104 promoter and ORF (except for the C-terminal region) with the LEU2 gene by using the technique described previously (8) .
Plasmids. The centromeric plasmids pYS104 (URA3), containing the HSP104 gene under its own promoter, pH28 (HIS3) and pYSGal-104 (URA3), bearing the HSP104 gene under the galactose-inducible GAL1,10 (GAL) promoter, plasmid pGAL-SSA1 (URA3), bearing the SSA1 gene under the GAL promoter, and matching control plasmids with the GAL promoter, pLA1 (HIS3) and pRS316GAL (URA3), were described earlier (see reference 7 for sources). All these plasmids except pRS316GAL were provided by S. Lindquist. The plasmid pKT218,620, provided by S. Lindquist, is a pYS104 derivative with two Lys-toThr substitutions generated at codons 218 and 620 of the HSP104 gene. These substitutions inactivate both ATP binding sites of Hsp104 (33) . The plasmid pUK21-KT218,620 was constructed by inserting the XhoI-EcoRI fragment of HSP104 obtained from the plasmid pKT218,620 into XhoI-EcoRI-digested plasmid pUK21 (50) . The HIS3-based plasmid pLA1-HSP104-KT and URA3-based plasmid pRS316GAL-HSP104-KT, which express the HSP104-KT218,620 double mutant allele under the GAL promoter, were constructed by inserting the 3.2-kb BamHI-SpeI fragment of mutant HSP104 from pUK21-KT218,620 into BamHISpeI-digested pLA1 and pRS316GAL, respectively. The TRP1-based centromeric plasmids pFL39-GAL-HSP104 and pFL39-GAL-HSP104-KT were constructed by inserting the XhoI-SacI GAL-HSP104 fragment from plasmids pH28 and pLA1-KT218,620, respectively, into SacI-SalI-digested pFL39 (3). The pHGPm104 plasmid is a derivative of pH28, containing a portion of the endogenous HSP104 promoter inserted between the GAL promoter and the HSP104 ORF in the same orientation. To construct this plasmid, the 291-bp piece of HSP104 immediately adjacent to the 5Ј end of the HSP104 ORF was PCR amplified from pYS104 by using the primers HSP104-300 (5Ј-GAGGATCCAT GCCAGAATTTTCTAGAAGGG) and HSP104 (-10)-REV (5Ј-TCGGATCCA  TATTTTATGGTACGTGTAGTTG) , purchased from GIBCO-BRL (Gaithersburg, Md.) and containing BamHI extensions (restriction sites are underlined). The PCR fragment was digested with BamHI and inserted into the BamHI site of pH28. The resulting chimeric GAL-HSP104 promoter (P MOD ) assures constitutive HSP104 expression at 4 to 5% (see below) of the normal level and is affected by neither galactose nor heat shock (data not shown). The construction of centromeric plasmid pLSpSUP35NM-GFP, containing the SUP35NM region fused in frame to superglow green fluorescent protein (GFP) and expressed under the SUP35 endogenous promoter, has been described previously (2) . The multicopy 2m DNA-based LEU2 plasmid pSTR7, bearing the SUP35 gene under its own promoter, and centromeric HIS3-based plasmid pLA1-SUP35, bearing the SUP35 gene without the C terminus under the GAL promoter, were used for the induction of [PSI ϩ ] appearance in the [psi Ϫ PIN ϩ ] strain as described earlier (7) .
Media and growth conditions. Yeast cultures were grown at 30°C unless otherwise noted. Standard yeast media and standard procedures for yeast cultivation, phenotypic and genetic analysis, transformation, sporulation, and dissection were used (19) . Synthetic media lacking adenine, histidine, leucine, lysine, tryptophan, and uracil are designated ϪAde, ϪHis, ϪLeu, ϪLys, ϪTrp, and ϪUra, respectively. In all cases where the carbon source is not specifically indicated, 2% glucose (Glu) was used. The synthetic medium containing 2% galactose (Gal) or Gal and 2% raffinose (GalϩRaf) instead of glucose was used to induce the GAL promoter. Liquid cultures were grown with at least a 1/5 liquid/flask volumetric ratio in a shaking incubator (200 to 250 rpm).
Assays ϩ Lys ϩ diploids with GT17. These diploids were tested for the presence of [PSI ϩ ] as described above. As only one fourth of all spores contained both MAT␣ and hsp104⌬::URA3, analysis of prion maintenance in the mitotic progeny of individual spores, especially for periods longer than two generations, would become too laborious without prior identification of the spores of the desired genotype. To identify MAT␣ cells, the newly isolated spores were placed immediately next to a dense patch of MAT␣ cells on YPD medium that had been prepared 2 to 3 h earlier to allow ␣-factor to be secreted and diffused through the medium. The spores were monitored for 2 to 5 h. The MAT␣ spores were distinguished by their ability to initiate bud formation, in contrast to G 1 -arrested (shmoo) MATa spores (47) . To identify the hsp104⌬:: URA3 (Ura ϩ ) cells, the MAT␣ spores were transferred onto ϪUra medium with triple amounts of all necessary amino acids and quadruple amounts of adenine and methionine. Only Ura ϩ cells were able to continue budding on this medium. These cells were allowed to divide for the desired number of generations. The number of generations was calculated as log 2 N, where N is the number of cells in a microcolony counted under microscopic examination. The individual cells from each microcolony were then picked up and cell-to-cell mated to GT17 on YPD medium. After 2 to 3 days, colonies were picked, checked on ϪUra-Lys medium, lacking both uracil and lysine, to confirm diploid status, and tested for the presence of [ In this way, only cells which retained the plasmid throughout the whole period of induction on Gal medium were scored. At least eight independent transformants were tested for each strain-plasmid combination.
Quantitation of prion curing. For quantitative analysis of prion curing by overproduced wild-type or mutant Hsp104, transformants containing the plasmids with GAL-HSP104 or GAL-HSP104-KT constructs were grown in synthetic liquid Glu medium selective for the plasmid, washed, and inoculated into synthetic plasmid-selective GalϩRaf medium at the starting concentration of 10 5 cells/ml. Growth was monitored by counting the cells, and cultures were maintained in the exponential phase of growth by periodically diluting them with fresh medium. Aliquots were taken after certain periods of time and were plated onto synthetic plasmid-selective Glu medium. . The number of generations (G) for the time period t was calculated according to the following formula: G ϭ log 2 (C t /C 0 ) where C t is the concentration of the viable plasmid-containing cells at time point t and C 0 is the concentration of the viable plasmid-containing cells at the starting point. Concentrations of viable plasmid-containing cells were determined from the numbers of colonies grown on selective medium. Curing by 5 mM GuHCl was quantified in exactly the same way except that the strains did not contain the galactose-inducible plasmids, both cultures growing in synthetic GalϩRaf medium and cultures growing in YPD medium were analyzed for the comparison, aliquots were plated onto YPD medium, and all viable cells rather than only plasmid-containing cells were counted to calculate the numbers of generations.
DNA and protein analysis. Standard procedures were used for isolation of DNA, restriction digestion, ligation, and bacterial transformation (39) . Enzymes were purchased from New England Biolabs and GIBCO-BRL. The thermal cycler was from Ericomp, Inc. Plasmid copy number was determined by Southern hybridization with the labeled 0.5-kb PvuI-PvuII fragment of pH28 containing the HSP104 C-terminal region present in both the disrupted chromosomal copy of HSP104 and the plasmid copy of HSP104. Yeast DNA cut with PvuII contained two fragments homologous to this probe: a 4.5-kb chromosomal fragment, used as a loading control, and a 1.3-kb plasmid fragment. Chemiluminescent labeling and hybridization were performed according to Amersham protocols. Protein isolations and analyses were performed according to previously described techniques (see reference 31).
Antibodies. The monoclonal mouse antibody to Hsp104 was a gift of S. Lindquist. The rabbit polyclonal antibodies to tagged Sup35NM were produced by Cocalico, Inc. Albumin and proteases were removed from the serum by using Affi-Gel (Blue) from Bio-Rad according to Bio-Rad protocols. Bacterial expression vector used to produce the His 6 -tagged Sup35NM fragment was constructed by P. A. Bailleul-Winslett via insertion of the 0.75-kb EcoRI-HpaI fragment from the plasmid pCEN-GAL-SUP35 (11) into the plasmid pET-32b(ϩ), purchased from Novagen and cut with EcoRI and XhoI (XhoI-generated sticky ends were blunted with DNA polymerase I). The resulting construct contains essentially all of the Sup35NM region, with an N-terminal extension, including the His 6 , Trx, and S tags, under the control of the T7 promoter. T7 expression was induced by isopropyl-␤-D-thiogalactopyranoside in Escherichia coli strain AD494 (DE3), purchased from Novagen and bearing the T7 RNA polymerase gene under control of the P lac promoter. The tagged Sup35NM protein was isolated and purified by chromatography on Ni 2ϩ columns according to the Novagen protocols, with slight modifications. Western blotting and reaction to antibodies were performed according to Amersham protocols. The ECL detection kit from Amersham was used. Densitometry measurements were performed by using the program Alphaimager 2000 from the Alpha Innotech Corporation.
Fluorescence microscopy. Live images of GFP distribution in the exponentially growing yeast cells containing the plasmid pLSpSup35NM-GFP were obtained as described previously (2) . The fixed cells for GFP imaging and immunostaining were prepared by adding formaldehyde directly to the culture, up to a final concentration of 4%, and incubating cultures for 15 min at 25°C. To destroy the cell wall, cells were then gently spun down, washed twice in solution B (100 mM potassium phosphate buffer, pH 7.5, with 1.2 M sorbitol), resuspended in 1 ml of the same solution, treated by adding 2 l of 2-mercaptoethanol and 20 l of a lyticase (1 mg/ml), incubated for 30 min at 37°C, precipitated again, and washed twice with solution B. For immunostaining, fixed cells with destroyed cell walls were resuspended in 100 l of solution F (100 mM potassium phosphate buffer, pH 7.4, 1 mg of bovine serum albumin/ml, 15 mM sodium azide, 15 mM sodium chloride) containing the Sup35 antibody, incubated in the dark for 1 h, washed 10 times with solution F, and resuspended in solution F containing rhodamineconjugated anti-mouse secondary antibodies purchased from Sigma. After 1 h of incubation in the dark, cells were washed 10 times with solution F and resuspended in phenylenediamine mounting solution (1 mg of p-phenylenediamine/ml [Sigma] in 1ϫ phosphate-buffered saline and 90% glycerol) (36) . Preparation for imaging was accomplished by placing an aliquot of cells onto a glass slide and sealing the coverslip to the slide with clear nail polish. The samples were scanned using a Zeiss LSM510 UV confocal laser scanning microscope (Carl Zeiss Inc., New York, N.Y.), and image analysis was conducted using the Zeiss LSM Image browser (Carl Zeiss, Jena, Germany) as described previously (2) . The excitation wavelength was 543 nm for the helium-neon laser (rhodamine fluorescence) and 488 nm for the argon laser used to visualize GFP. (Table 2) .
RESULTS

Hsp104⌬ causes rapid loss of [PSI
To interpret these data, one should compare the kinetics of [PSI ϩ ] loss to the behavior of Hsp104 protein during sporulation and germination. It is known (40) and confirmed by us (Fig. 1A) that Hsp104 levels are increased during sporulation. Protein analysis data show that transition from sporulating to the germinating cultures is accompanied by a significant decrease in Hsp104 levels (Fig. 1A) , possibly due to a partial loss of cytoplasm in the process of spore formation. However, average levels of the Hsp104 protein in the population of germinating ascospores originating from the heterozygous HSP104 ϩ / hsp104⌬ diploid are about the same as those in the population of germinating ascospores originating from the isogenic homozygous HSP104 ϩ /HSP104 ϩ diploid (Fig. 1A) , despite the fact that about half of the spores in the former population lack the HSP104 gene. In contrast, the approximately twofold difference in Hsp104 protein levels between these populations becomes evident after the first two mitotic divisions following germination (Fig. 1A) . This confirms that the HSP104 ϩ and hsp104⌬ ascospores originating from the Hsp104 ϩ diploid initially contain approximately equal amounts of the Hsp104 protein, and loss of Hsp104 occurs in mitotic cell divisions following germination. This observation easily explains retention of [PSI ϩ ] by the hsp104⌬ ascospores. The question remains whether Hsp104 protein is quickly degraded once ascospores resume vegetative growth or whether its levels decrease slowly due to dilution of preexisting Hsp104 in cell divisions. Direct measurements of the Hsp104 protein levels in the mixed population originated from the sporulating HSP104 ϩ /hsp104⌬ culture are not sensitive enough to answer this question due to the presence of a large number of HSP104 ϩ cells continuously producing Hsp104. In order to study the kinetics of Hsp104 loss in mitotically dividing yeast cells, we induced expression of the GAL-HSP104 construct in the hsp104⌬ strain (isogenic to GT84, used in the rescue experiment) on GalϩRaf medium and measured Hsp104 levels at various periods of time after GAL-HSP104 expression was turned off by shifting to Glu medium. Our data (Fig. 1B) are consistent with the model suggesting that degradation of 3A) . In contrast, more than 80% of cells remained [PSI ϩ ] after one generation, and more than 40% remained [PSI ϩ ] after four generations in the culture which overproduced both wildtype and mutant Hsp104 together (Fig. 3A) . Therefore, wildtype and mutant Hsp104 interfere with each other's [PSI ϩ ] curing effects, as would be expected if mutant Hsp104-KT acts by inactivating wild-type Hsp104.
We have also asked whether mutant Hsp104-KT would interfere with the activity of wild-type Hsp104 in the temperature tolerance assays. Our results (Fig. 3B) /hsp104⌬) were sporulated in liquid sodium acetate medium. The ascii were destroyed by lyticase treatment followed by intense vortexing, and the ascospores were shifted to the synthetic glucose medium to germinate and resume growth. Aliquots of cultures were taken at the following time points: (i) before sporulation; (ii) after 3 days of incubation in the sporulation medium, when more than 90% of cells produced ascii; and (iii) at various time points after the shift to glucose medium. Proteins were isolated, run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and reacted to Hsp104 antibody. Coomassie staining was used to verify that equal amounts of total protein were loaded in each case. Both strains contain similar amounts of Hsp104 protein at the earlier stages of germination. However, the difference between the GT81-originated culture (containing only HSP104 ϩ cells) and the GT84-originated culture (containing a mixture of HSP104 ϩ and hsp104⌬ cells) becomes evident after two mitotic divisions following germination. (B) Loss of Hsp104 protein after inactivation of the HSP104 gene in the mitotically dividing cells occurs by dilution rather than by degradation. The hsp104⌬ strains GT241-2B and GT241-3B were transformed separately with the plasmid pH28 (HIS3-GAL-HSP104). Cultures were grown in ϪHis/ GalϩRaf for 20 to 22 h to induce GAL-HSP104 and then were washed and shifted to ϪHis/Glu, where GAL-HSP104 is repressed. The control experiment (not shown) confirmed that no detectable Hsp104 is produced by GAL-HSP104 on glucose medium. Total protein lysates were collected at various time points. Proteins were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and were reacted to Hsp104-specific antibodies. Relative Hsp104 protein amounts were quantified by using densitometry as described in Materials and Methods. Observed levels are reported as the percentage of protein remaining relative to point 0 (time of shift to ϪHis/Glu). Expected values in percentages (E) was determined from the equation E ϭ 100/(2 X ) where X is the number of generations, under the assumption that no protein degradation occurs. Data confirm that a decrease in Hsp104 levels occurs due to dilution rather than degradation.
presence of Hsp104-KT decreases induced thermotolerance of yeast cultures previously shown to result from activity of wildtype Hsp104 (40) . This agrees with observations of another group (44) ]-mediated nonsense suppression was reduced in the cultures that underwent simultaneous overexpression of Hsp70-Ssa and Hsp104-KT compared to that of the cultures that overexpressed Hsp104-KT alone. This reduction resulted in a more intense red color on YPD medium (Fig. 3D) (Fig. 4C) . As wild-type and mutant Hsp104 were induced in the synthetic GalϩRaf medium, the GuHCl-induced curing of [PSI ϩ ] was also studied in both YPD (as described previously) and GalϩRaf media. Although GT81-1C and OT56 were more resistant to the [PSI ϩ ] curing effect of GuHCl in GalϩRaf medium than in YPD medium, it did not change the general picture. In all cases, no statistically significant [PSI ϩ ] loss was observed for the first 4 to 5 (strong [PSI ϩ ] strains GT81-1C, Fig. 4A, and OT56, Fig. 4C ) or 3 to 4 (weak [PSI ϩ ] strain OT55, Fig. 4B ) cell divisions in the presence of GuHCl, confirming the existence of a lag period apparently required for dilution of preexisting [PSI ϩ ] replicating units (12) . In contrast, cultures overexpressing either wild-type or mutant Hsp104 did not exhibit this lag. Usually the [psi Ϫ ] cells were detected in the very first cell divisions after induction (Fig. 4) Table 2 , are also shown in Fig. 4A for the comparison). The only difference was a short two-division lag phase observed in the case of hsp104⌬, which should be attributed to the necessity to dilute the preexisting Hsp104, as argued above (Fig. 1) . It is worth noting that the weak [PSI ϩ ] strain OT55 was more sensitive to the curing effect of wild-type Hsp104 but not to the curing effect of Hsp104-KT than was the isogenic strong [PSI ϩ ] strain OT56 ( Fig. 4B and C Antagonistic interactions between mutant and wild-type Hsp104 in thermotolerance. Strain OT60 was transformed with the URA3 plasmid pKT218,620 bearing HSP104-KT under the endogenous HSP104 promoter (Hsp104-KT) or matching control plasmid (Control). Transformants were grown either in the synthetic ϪUra medium (which is selective for the plasmid and causes slight induction of Hsp104) or in YPD medium at 25°C. In YPD cultures, HSP104 expression was induced by a 30-min pretreatment at 37°C prior to heat shock (40) . Cultures were heat shocked at 50°C, and serial dilutions were spotted onto ϪUra medium. Plates were photographed after 3 days of incubation. The plasmid pKT218,620 greatly decreases the thermotolerance of the culture, confirming the dominant-negative effect of Hsp104-KT. The same result was reproduced with strain GT17 (not shown). (C) Effects of Hsp104-Ssa on [PSI ϩ ] curing: the quantitative assay. Yeast strain, OT56; plasmids, pH28 ϩ pRS316GAL (Hsp104), pH28 ϩ pGAL-SSA1 (Hsp104 ϩ Ssa), pLA1-HSP104-KT ϩ pRS316GAL (Hsp104-KT), and pLA1-HSP104-KT ϩ pGAL-SSA1 (Hsp104-KT ϩ Ssa). Production of the Hsp104, Hsp104-KT, and Hsp70-Ssa proteins was induced in the liquid ϪUra-His/GalϩRaf medium. The number of generations after induction is shown. Excess Hsp70-Ssa protects [PSI ϩ ] from curing by excess Hsp104 but not from curing by excess Hsp104-KT. (D) Effects of Hsp70-Ssa on [PSI ϩ ] curing: the color assay. Yeast strain, OT56; plasmids, pLA1 (Control), pGAL-SSA1 (1Ssa), pH28 (1Hsp104), pH28 ϩ pGAL-SSA1 (1Hsp104 ϩ 1Ssa), pLA1-HSP104-KT (1Hsp104-KT), and pLA1-HSP104-KT ϩ pGAL-SSA1 (1Hsp104-KT ϩ 1Ssa). Transformants were grown on solid ϪUra-His/Gal medium and were then velveteen replica plated onto YPD medium and analyzed by color phenotype. A lighter color is indicative of more intense suppression, apparently due to a larger proportion of [ (Fig. 3D) . The light-pink and sectored redpink colonies always retained the [HIS3 P MOD -HSP104] plasmid, while red colonies could be both His ϩ (plasmid-containing) and His Ϫ (containing no plasmid). The light-pink colonies and lighter sectors of red-pink colonies remained unstable and produced all three phenotypes in the further subcloning steps (not shown). Frequency of spontaneous mitotic loss of the plasmid was significantly lower in the cells originating from light-pink colonies than that of sectored red-pink His ϩ colonies and red His ϩ colonies (data not shown). Southern hybridization analysis demonstrated that light-pink isolates contain more copies of the [HIS3 P MOD -HSP104] plasmid per cell than sectored red-pink isolates, while the latter ones contain more plasmid copies per cell than did red isolates (Fig. 5C) Decreased Hsp104 levels or activity results in decreased number and increased size of prion aggregates. Cultures with decreased levels of Hsp104 and cultures overexpressing the dominant-negative allele of HSP104 provide a unique opportunity to visualize prion aggregates in the process of their loss due to decreased Hsp104 levels or activity. For this purpose we used a SUP35NM-GFP fusion construct under the control of the endogenous SUP35 promoter (P SUP35 ). The previously described constructs, overexpressing Sup35NM-GFP from the strong constitutive or inducible promoter, produced large flu- Table 2 . These results were obtained by dissecting the diploid GT84, which is isogenic to GT81-1C. (34) . In contrast, the moderate levels of Sup35NM-GFP production from P SUP35 normally gave rise to a large number of very small Sup35NM-GFP aggregates, which were almost uniformly distributed throughout the HSP104 ϩ [PSI ϩ ] control cells ( Fig. 6A  and E ; see also reference 2 for a comparison). This makes it difficult to distinguish between [psi Ϫ ] and [PSI ϩ ] cells by using the P SUP35 -SUP35NM-GFP construct in normal growth conditions, although such a distinguishment could be improved by freezing the Sup35NM-GFP aggregates and making them more visible after treatment with protein synthesis inhibitors (2). However, this feature makes the P SUP35 -SUP35NM-GFP construct a sensitive tool for identifying the conditions which reduce numbers and increase sizes of the Sup35NM-GFP aggregates in the yeast cells.
Indeed, we have observed that the unstable [PSI ϩ ] culture originating from the low-Hsp104 (hsp104⌬ [P MOD -HSP104]) strain exhibits a mode of Sup35NM-GFP aggregation that is markedly different from that of the isogenic [PSI ϩ ] culture with normal levels of Hsp104. While about 98.5% of cells in the normal [PSI ϩ ] culture contained almost indistinguishable small aggregates diffused all over the cell cytoplasm, about 84% of cells in the low-Hsp104 [PSI ϩ ] cultures contained either medium-size aggregates (present in a smaller number per cell but clearly visible due to larger average aggregate size) or very large agglomerates (usually only one or very few per cell) ( Fig. 6A and C) . Some cells contain these agglomerates in the form of bars or rings (not shown). Neither medium-size Sup35NM-GFP aggregates nor huge Sup35NM-GFP agglomerates were ever detected in the red (that is, completely cured [psi Ϫ ]) derivatives of the same low-Hsp104 strain. This confirms that appearance of the visible aggregates is [PSI ϩ ] dependent and is not caused simply by the Sup35NM-GFP folding defect in the absence of Hsp104 function.
Quite remarkably, the percentage of cells containing huge agglomerates was proportional to the stability of [PSI ϩ ] in the low-Hsp104 cultures. The light-pink low-Hsp104 isolate that produced about 9% of [psi Ϫ ] (red) colonies contained about 11% of cells with one or very few huge Sup35NM-GFP agglomerates, while the sectored red-pink low-Hsp104 isolate that produced about 25% of [psi Ϫ ] colonies contained about 26% of cells with one or very few huge Sup35NM-GFP agglomerates (Fig. 6D ). While such an exact correspondence of these numbers could be a coincidence, the tendency observed clearly indicates that increased aggregate size correlates with decreased ability to transmit the prion state, suggesting that huge agglomerates represent the dead ends of the prion replication cycle.
As one could suggest that behavior of the endogenous Sup35 protein is different from that of the Sup35NM-GFP fusion construct, we have also attempted to identify the endogenous Sup35 aggregates by immunostaining. Compared to GFP tagging, this procedure produced less clear images and more intense backgrounds that could be due in part to lower specificity of the polyclonal Sup35 antibody. However, we were able to identify the large Sup35 aggregates in the [PSI ϩ ] low-Hsp104 culture (Fig. 6B) , thus confirming that data obtained by the GFP-based approach reflect actual behavior of the Sup35 protein in the [PSI ϩ ] low-Hsp104 cells. To confirm that increased aggregate size is indeed associated with the loss of Hsp104 activity, we used an alternative approach to inactivate Hsp104: overproduction of the dominantnegative mutant Hsp104-KT. Indeed, induction of the GAL-HSP104-KT construct in the [PSI ϩ ] strain also resulted in decreased numbers and increased sizes of the Sup35NM-GFP aggregates: after 18 h of incubation on Gal medium, each cell of the predominant (91%) class contained relatively low numbers of medium-size aggregates similar to those detected in the majority of the cells in the low-Hsp104 culture and clearly distinguishable from the numerous small aggregates detected in the isogenic [PSI ϩ ] control ( Fig. 6E and F) . As only 15% of cells in the culture that had undergone Hsp104-KT induction for that period of time were still able to form the [PSI ϩ ] colonies, it is clear that at least some of the aggregates observed lost the ability to transmit the prion state. No huge agglomerates were observed in these experimental conditions. This could be due to the fact that the relatively short time period that passed after Hsp104-KT induction is insufficient for the prion aggregates to grow into huge agglomerates. In contrast, the overproduction of wild-type Hsp104 (also curing yeast cells of [PSI ϩ ] with about the same efficiency as that of Hsp104-KT; see Fig. 4 ) did not increase aggregate size (Fig. 6E ), which agrees with the previously reported ability of Hsp104 to solubilize prion aggregates (34, 35) . In the same way, no medium size aggregates or huge agglomerates were detected in the isogenic (GT81-1C) yeast culture growing in the presence of GuHCl (Fig. 6A) . This confirms that loss of [PSI ϩ ] in conditions other than Hsp104 depletion does not necessarily proceed via the large aggregate stage.
DISCUSSION
Comparison between prion-curing effects of Hsp104 inactivation and GuHCl. If the function of Hsp104 is required for formation of new prion molecules (8, 34) , one would expect that prion loss following Hsp104 inactivation would occur by dilution of preexisting prion units. Such a mechanism has previously been reported for the prion-curing agent GuHCl (12) .
[PSI ϩ ] loss in the presence of GuHCl follows slow generationdependent kinetics with a long lag period that is required to decrease the average copy number of the prion aggregates. Calculations, based on kinetics of GuHCl-induced loss, suggested that the [PSI ϩ ] strain used in that work contains about 60 proliferating Sup35
PSIϩ units per cell (12) . Kinetics of [PSI ϩ ] curing in our strains (see Fig. 4 ) was generally similar to those reported previously (12) , although weak [PSI ϩ ] was lost faster than the strong one, as expected (see Fig. 4 ). It appears that our strong [PSI ϩ ] strains contain about the same number of proliferating [PSI ϩ ] units as the strains used by Eaglestone et al. (12) . However, [PSI ϩ ] loss induced by Hsp104-KT did not show a significant lag period and followed rapid kinetics, strikingly different from that of GuHCl-induced loss in the same conditions (Fig. 4) . [PSI ϩ ] loss after elimination of the HSP104 gene has exhibited a short lag period for two cell divisions (Table 2 and Fig. 4A ), most likely due to the fact that the Hsp104 protein is very stable and remains in the cell for a long time after elimination of the HSP104 gene, so that Hsp104 concentration is decreased only due to protein dilution in the cell divisions (Fig. 1B) . After Hsp104 protein had been diluted below 25% of the normal wild-type level, the prion loss in hsp104⌬ cells followed rapid kinetics, indistinguishable from prion loss induced by Hsp104-KT (Fig. 4A and Table 2 ). This agrees with the results of another experiment indicating that cultures expressing Hsp104 at 35 to 40% of the normal levels (on average) are capable of maintaining the [PSI ϩ ] state in the majority of the cells (Fig. 5B) . 2B and Tables 2 and 3 ). There could be two possible explanations for such a discrepancy. One suggests that the long lag in GuHCl-mediated curing is not necessarily due to dilution of multiple prion units. Rather, it is due to the necessity to inactivate most of the Hsp104 molecules. Then GuHCl could still act by Hsp104 Correlation between these numbers suggests that huge Sup35 agglomerates possess reduced ability to transmit the prion state. Limits of variation (95%) are shown. (E and F) Effects of the overexpressed dominant-negative Hsp104-KT protein on Sup35NM-GFP aggregate size. The yeast strain used was GT81-1C; the inducible constructs were URA3-GAL-HSP104-KT (1Hsp104-KT) and URA3-GAL-HSP104 (1Hsp104). Media were ϪUra-Leu/Glu (before induction) and ϪUra-Leu/GalϩRaf after 18 h of incubation (1Hsp104-KT and 1Hsp104). After induction, about 91% of 50 cells screened in the 1Hsp104-KT culture exhibited detectable medium-size Sup35NM-GFP aggregates. (Fig. 6E) , the GFPtagged Sup35
PSIϩ aggregates were fewer and larger than those of the isogenic strains with normal levels of Hsp104. No such effect was observed for excess Hsp104 (Fig. 6E) or GuHCl (Fig. 6A) in the same strain. Reverse correlation between Hsp104 activity and aggregate size agrees with the previously proposed Hsp104 role in aggregate disassembly (25, 35 (45) .
Model for Hsp104 role in prion propagation. Our results confirm that a decrease in Hsp104 levels or activity results in a decreased number and increased size of prion aggregates, leading to the loss of prion reproductive activity. In general, this is consistent with the previously hypothesized role of Hsp104 in the production of the new prion seeds (25, 35) . However, one important clarification should be made. The original model proposed that the Hsp104-mediated seeding is required primarily for prion partitioning and segregation. However, our results show that prion loss caused by Hsp104 inactivation is rapid and cannot be explained simply by a segregation defect (Fig. 4 and Table 2 ). Most likely, prion aggregates constantly undergo cycles of assembly and disassembly in the yeast cell. The chaperone helpers regulate these processes, with Hsp104 being a primary catalyst of the disassembly step. Lack or shortage of Hsp104 function results in formation of the large aggregates with reduced ability to transmit the prion state.
There could be at least two nonexclusive explanations for the loss of prion-converting activity by these large aggregates. First, the total surface of all aggregates in the cell decreases dramatically with increase of the average aggregate size. This would decrease the fraction of prion protein that is able to interact with the soluble nonprion molecules. Second, the intracellular location of the large aggregates could also be altered so that they become inaccessible to the soluble Sup35 molecules. As a result, prion reproduction is inhibited and nonprion protein molecules are rapidly accumulated. Such a model agrees with the recent observations suggesting that huge inclusion bodies in aggregation-related disorders are not toxic, while proliferation of amyloid is probably associated with the smaller intermediates (see reference 21 for a review).
The fate of the large aggregates remains unclear. As they do not possess prion activity anymore, they cannot be monitored by genetic means. It is possible that the unrestricted increase of the aggregate size results in eventual elimination of these aggregates from the population due to death of the cells containing these large aggregates. Indeed, it has been observed that a significant fraction of cells containing huge ring-like aggregates of the overproduced Sup35-GFP are unable to form viable colonies (54) . It is also possible that large aggregates eventually lose their high-order organization and proteinase resistance, which leads to their destruction by the proteolytic systems.
Interaction of Hsp104 and Hsp70-Ssa in prion maintenance. The Hsp70-Ssa protein has previously been shown to protect [ (31) or by Hsp104-KT (Fig. 3C) . Moreover, excess Ssa1 protein enhanced an anti-[PSI ϩ ] effect of Hsp104-KT (Fig. 3D) . This indicates that a role of Hsp70-Ssa protein in [PSI ϩ ] maintenance is complex and depends on its functional interaction with Hsp104.
We suggest that the primary Hsp70-Ssa effect on prion aggregates is opposite to that of Hsp104. While Hsp104 catalyzes aggregate disassembly, Hsp70-Ssa promotes new rounds of aggregate assembly. In this way concerted action of Hsp104 and Hsp70-Ssa results in prion proliferation. Increased levels of Hsp104 result in intensification of aggregate disassembly that might lead to eventual monomerization and loss of prionforming activity. However, increased levels of Hsp70-Ssa, resulting in intensified assembly of new aggregates, could counteract such a process. In contrast, increased Hsp70-Ssa assembly-promoting function in a low-Hsp104 background would result in facilitated accumulation of the large aggregates, losing prion activity. This explains the opposite effects of excess Ssa1 on [PSI ϩ ] curing by Hsp104 overproduction and Hsp104 inactivation, which have been observed in our experiments.
At first glance, such a model would contradict the previously reported role of Hsp70-Ssa in solubilization of heat-damaged aggregated proteins. In that case, Hsp104 initiates the aggregate breakdown, while Hsp70-Ssa catalyzes the protein refolding back to the normal (soluble) state (15) . However, this difference could be due to unusual features of prions differing from the components of amorphous aggregates of heat-damaged misfolded proteins. As we have discussed previously (31), Hsp70-Ssa apparently does not recognize a prion as an abnormal or misfolded protein. Rather, it might recognize it as a damaged intracellular structural complex which needs protection and recovery.
It has been reported that [PSI ϩ ] response to excess Hsp70-Ssa is strain specific: the [PSI ϩ ]-mediated nonsense suppression was enhanced in some strains (31) and antagonized in other strains (8, 27 ) by overproduced Ssa1. Moreover, excess Hsp70-Ssa affected some, but not all, [PSI ϩ ] isolates in the same genetic background (24) . These discrepancies could potentially be explained by the differences in average aggregate size and the effective number of the prion replicating units that could be controlled by both genetic composition of the yeast strain (e.g., via the Hsp104/Hsp70 ratio) and by specific patterns of the prion strain. In this case, prions with the larger number of smaller seeds would be curable by excess Hsp104, which causes further dissociation of the seeds to monomers, but strengthened by excess Hsp70-Ssa, which counteracts this effect. On the other hand, prions with the smaller number of larger seeds would be insensitive to excess Hsp104 but curable by excess Hsp70-Ssa (that makes seeds even larger and inactive). At least in one case, such a correlation was indeed observed. The unstable [PSI ϩ ] prions formed by the heterologous Sup35NM (or Sup35N) domain of Pichia methanolica in S. cerevisiae (6) are insensitive to excess Hsp104 (23) , are curable by excess Hsp70-Ssa (24) , and exhibit smaller numbers and larger average sizes of the GFP-tagged aggregates than the endogenous stable S. cerevisiae [PSI ϩ ] prions in the same genotypic background (E. Lewitin and Y. O. Chernoff, unpublished data). The experiments aimed at further testing this model are presently under way.
Our data confirm that the chaperone machinery of the yeast cell is adjusted to levels that are optimal for prion reproduction. It remains a mystery how such an adjustment could have evolved. Recent evidence, pointing to the involvement of chaperones of the Hsp100 and Hsp70 groups in control of aggregation of poly-Gln proteins of various origins (4, 20, 22, 30, 41, 51) , supports evolutionary conservation of this regulatory mechanism. Further understanding of the chaperone-based regulation of aggregate propagation can therefore help in the fight against amyloidoses and other aggregation-related disorders. Moreover, prion modulation by the stress-regulated chaperones provides a mechanism for environmental changes to cause inherited protein alterations. If protein-based genetic variations play a beneficial role by increasing the inherited variability of population in the changing environment as hypothesized recently (5, 48) , such a mechanism could significantly influence our understanding of interactions between organism and environment in the process of evolution.
